Fundz

Pharosyn raises $3M seed round led by Moonfire Ventures to accelerate pharma's commercial decisions with AI-powered intelligence tools.

PRIVATESep 02, 2026

Amount Raised

$3 Million

Round Type

Seed

Greater LondonBiotechnologyArtificial IntelligenceAnalyticsMachine Learning

Investors

General AdvanceTranspose PlatformEntrepreneurs FirstMoonfire Ventures

Description

Pharosyn, a London-based AI startup, has raised $3 million in seed funding led by Moonfire Ventures, with participation from Entrepreneurs First, Transpose Platform, and General Advance. The company develops AI systems for pharmaceutical companies' commercial departments, enabling them to produce reports in 15 minutes instead of four hours. Pharosyn is collaborating with top-ten biopharmaceutical companies and mid-sized pharma firms on commercial and competitive intelligence. The funding will help the company address pharmaceutical companies' need for faster decision-making on pricing, market access, and portfolio management.

Who to call at Pharosyn, and when

A new round usually means Pharosyn is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pharosyn raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pharosyn, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pharosyn. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pharosyn

Location

Greater London, England, United Kingdom

About

Pharosyn is a London-based AI startup that develops custom AI systems for pharmaceutical companies' commercial departments, focusing on commercial and competitive intelligence rather than drug discovery. The company's tools reduce report generation time from four hours to 15 minutes by tracking clinical, regulatory, and commercial data sources including trial data, deals, and hiring trends. Built on Cambridge research about mitigating hallucinations in large language models, Pharosyn emphasizes traceability and custom AI infrastructure embedded directly within commercial teams. The platform is used daily by senior executives at top-10 biopharmaceutical companies and mid-sized pharmaceutical firms to inform strategic decisions on pricing, market access, and portfolios.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pharosyn raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsStephen, Co-Founder and CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pharosyn's next move

See what Strategic adds

Pharosyn raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.